| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |